tenk.fyi

Beam Therapeutics Inc.

BEAMNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$139.7M

120.0% YoY

Net Income

-$80.0M

78.8% YoY

EPS

$-0.81

82.3% YoY

Cash

$294.9M

4.6% YoY

FY 2025 · As of 2025-12-31

No recent insider transactions found.

ProShowing last 90 days. Full 12+ month history available on Pro.
Upgrade